CSIMarket Company Name, Ticker, Industry, else..
 
Chromocell Therapeutics Corporation  (NYSEAMER: CHRO)
Other Ticker:  
 
 
Price: $1.6800 $0.11 7.006%
Day's High: $1.73 Week Perf: -4.55 %
Day's Low: $ 1.57 30 Day Perf: -2.89 %
Volume (M): 5 52 Wk High: $ 3.80
Volume (M$): $ 9 52 Wk Avg: $1.19
Open: $1.57 52 Wk Low: $0.45



 Market Capitalization (Millions $) 10
 Shares Outstanding (Millions) 6
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Chromocell Therapeutics Corporation


   Company Address: 4400 Route 9 South Freehold 7728 NJ
   Company Phone Number: 265-8266   Stock Exchange / Ticker: NYSEAMER CHRO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AMGN        2.12% 
BCRX        2.65% 
BIIB        2% 
EXEL        0.24% 
GILD   -3.3%    
MRNA        2.81% 
• View Complete Report
   



Clinical Study

Channel Therapeutics Advances Non-Opioid Pain Management with Promising NaV1.7 Inhibitor Results While Facing Competi...

Published Sat, Dec 28 2024 5:28 AM UTC

Non-Opioid Pain Management: Channel Therapeutics? Breakthrough in NaV1.7 Inhibitor DevelopmentIn the evolving landscape of pain management therapeutics, the need for effective non-opioid alternatives has never been more pressing. Channel Therapeutics Corporation, a pioneer in developing non-opioid pain treatment solutions, recently announced promising results from its precl...
Management Announcement

Channeling New Directions: Chromocell Therapeutics Transitions to Channel Therapeutics Corporation Amidst Market Shifts

Published Thu, Nov 21 2024 2:49 PM UTC

In a strategic move aimed at better aligning its identity with its mission, Chromocell Therapeutics Corporation (NYSE American: CHRO) has officially changed its name to Channel Therapeutics Corporation as of November 18, 2024. This decision coincides with the company?s reincorporation in the State of Nevada. The new name, Channel Therapeutics, is particularly significant as ...
Stocks on the Move

Chromocell Therapeutics Corporation Assessing Performance and Investment Potential

Published Wed, Jul 10 2024 3:44 AM UTC

Chromocell Therapeutics Corporation, a pharmaceutical company specializing in the development of therapeutics for rare diseases, has been experiencing a trailing performance compared to the overall market. In this article, we will examine recent events and market trends to shed light on the investment potential of Chromocell Therapeutics Corporation.Assessing Recent Events:O...
Stock Market Announcement

Chromocell Therapeutics: Pioneering Non-Opioid Pain Treatment Signals Potential Stock Surge

Published Tue, Apr 9 2024 12:30 PM UTC



FREEHOLD, N.J., April 09, 2024 - Chromocell Therapeutics Corporation (Chromocell), a leading innovator in the development of non-opioid pain treatment therapeutics, recently shared significant news that promises to have a profound impact on the company and its shareholders. In a letter addressed to stockholders, Chromocell s Chief Executive Officer, Frank Knuettel,...
Product Service News

Chromocell Launches Cutting-Edge Eye Pain Treatment Program, Appoints Renowned Expert Dr. Simon Chandler to Spearhead Revolutionary Therapies in $2.5 Billion Market

Published Thu, Mar 21 2024 12:30 PM UTC

Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler: Targeting the Lucrative $2.5 Billion Eye Pain MarketNew Jersey-based biotechnology company, Chromocell, has officially announced the launch of its groundbreaking Eye Pain Treatment Program aimed at catering to the estimated $2.5 billion eye pain market. Bolstering this mileston...









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com